1. Home
  2. JYNT vs ACOG Comparison

JYNT vs ACOG Comparison

Compare JYNT & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$9.17

Market Cap

117.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.92

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
ACOG
Founded
2010
2000
Country
United States
Canada
Employees
N/A
57
Industry
Multi-Sector Companies
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
117.3M
110.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JYNT
ACOG
Price
$9.17
$5.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$17.00
$16.00
AVG Volume (30 Days)
69.0K
29.6K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
N/A
EPS
0.09
N/A
Revenue
$117,696,356.00
N/A
Revenue This Year
$12.23
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
$102.44
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$4.50
52 Week High
$13.47
$10.88

Technical Indicators

Market Signals
Indicator
JYNT
ACOG
Relative Strength Index (RSI) 53.40 48.35
Support Level $8.49 $5.73
Resistance Level $9.33 $6.34
Average True Range (ATR) 0.37 0.38
MACD 0.06 0.00
Stochastic Oscillator 58.90 64.13

Price Performance

Historical Comparison
JYNT
ACOG

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: